Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3655019018 | Dual delayed-release oral capsule (dose form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3655020012 | Dual delayed-release oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dual delayed-release oral capsule | Is a | Gastro-resistant oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Dual delayed-release oral capsule | Has dose form administration method | Swallow | true | Inferred relationship | Existential restriction modifier | ||
| Dual delayed-release oral capsule | Has dose form transformation | No transformation | true | Inferred relationship | Existential restriction modifier | ||
| Dual delayed-release oral capsule | Has dose form intended site | Oral | true | Inferred relationship | Existential restriction modifier | ||
| Dual delayed-release oral capsule | Has dose form release characteristic | Dual delayed-release | true | Inferred relationship | Existential restriction modifier | ||
| Dual delayed-release oral capsule | Has basic dose form | Capsule | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dexlansoprazole 60mg dual delayed-release oral capsule | Has manufactured dose form | False | Dual delayed-release oral capsule | Inferred relationship | Existential restriction modifier | |
| Dexlansoprazole 30mg dual delayed-release oral capsule | Has manufactured dose form | False | Dual delayed-release oral capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR